Skip to main content

Table 4 By-category comparison between genotypes of proportion of cases developing CKD

From: Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic

  

Proportion

%

p-value

At least CKD3

Non-PKD2

48/105

46

0.15

 

PKD2

8/25

32

 

At least CKD4

Non-PKD2

23/105

22

0.21

 

PKD2

3/25

12

 

CKD5 or RRT

Non-PKD2

14/105

13

0.04

 

PKD2

0/25

0

 
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us